COCRYSTAL PHARMA, INC. Increase (Decrease) in Accounts Payable
COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Accounts Payable of -$380.41 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2013-11-18
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2013-09-30 was -$1.50M.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2013-06-30 was $385.65K, a 11.85% decline year-over-year.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2013-03-31 was $730.81K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2012-12-31 was -$321.40K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts payable for fiscal 2012 was -$880.39K, a 234.98% decline from fiscal 2011.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts payable for fiscal 2011 was $652.24K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts payable for fiscal 2010 was -$58.84K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2013-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | -$1.11M derived: sum of 2 quarters · filed 2013-11-18 | -$380.41K 10-Q · filed 2013-11-18 | -$701.81K derived: sum of 4 quarters · filed 2013-11-18 | |
| 2013-06-30 | $385.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $1.12M 10-Q · filed 2013-08-15 | $795.06K derived: sum of 3 quarters · filed 2013-08-15 | $245.09K derived: sum of 4 quarters · filed 2013-11-18 | |
| 2013-03-31 | $730.81K 10-Q · filed 2013-05-10 | $409.41K derived: sum of 2 quarters · filed 2013-05-10 | -$140.56K derived: sum of 3 quarters · filed 2013-11-18 | $296.92K derived: sum of 4 quarters · filed 2013-11-18 | |
| 2012-12-31 | -$321.40K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$871.37K derived: sum of 2 quarters · filed 2013-11-18 | -$433.89K derived: sum of 3 quarters · filed 2013-11-18 | -$880.39K 10-K · filed 2013-04-01 | |
| 2012-09-30 | -$549.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | -$112.49K derived: sum of 2 quarters · filed 2013-11-18 | -$558.99K 10-Q · filed 2013-11-18 | -$597.48K 10-Q · filed 2012-11-14 | -$1.66M derived: sum of 4 quarters · filed 2013-11-18 |
| 2012-06-30 | $437.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | -$9.02K 10-Q · filed 2013-08-15 | -$1.11M derived: sum of 3 quarters · filed 2013-08-15 | $172.16K derived: sum of 4 quarters · filed 2013-08-15 | |
| 2012-03-31 | -$446.50K 10-Q · filed 2013-05-10 | -$1.55M derived: sum of 2 quarters · filed 2013-05-10 | -$265.32K derived: sum of 3 quarters · filed 2013-05-10 | $476.35K derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $181.19K derived: sum of 2 quarters · filed 2013-04-01 | $922.86K derived: sum of 3 quarters · filed 2013-04-01 | $652.24K 10-K · filed 2013-04-01 | |
| 2011-09-30 | $1.28M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $2.02M derived: sum of 2 quarters · filed 2012-11-14 | $1.75M 10-Q · filed 2012-11-14 | $1.56M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $741.67K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-28 | $471.05K 10-Q/A · filed 2012-09-28 | $281.78K derived: sum of 3 quarters · filed 2012-10-02 | -$404.02K derived: sum of 4 quarters · filed 2012-10-02 | |
| 2011-03-31 | -$270.62K 10-Q/A · filed 2012-10-02 | -$459.89K derived: sum of 2 quarters · filed 2012-10-02 | -$1.15M derived: sum of 3 quarters · filed 2012-10-02 | ||
| 2010-12-31 | -$189.28K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$875.08K derived: sum of 2 quarters · filed 2012-04-16 | -$58.84K 10-K · filed 2012-04-16 | ||
| 2010-09-30 | -$685.80K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $130.43K 10-Q · filed 2011-11-21 | |||
| 2010-06-30 | $816.23K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |